| 1 |
Mazzucco S, Diomedi M, Qureshi A, et al. Transcranial doppler screening for stroke risk in children with sickle cell disease: a systematic review [J]. Int J Stroke, 2017, 12(6): 580-588.
|
| 2 |
Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation [J]. Nat Med, 2011, 17(7): 796-808.
|
| 3 |
Nakamura K, Shichita T. Cellular and molecular mechanisms of sterile inflammation in ischaemic stroke [J]. J Biochem, 2019, 165(6): 459-464.
|
| 4 |
Muhammad S, Barakat W, Stoyanov S, et al. The HMGB1 receptor RAGE mediates ischemic brain damage [J]. J Neurosci, 2008, 28(46): 12023-12031.
|
| 5 |
Maroso M, Balosso S, Ravizza T, et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures [J]. Nat Med, 2010, 16(4): 413-419.
|
| 6 |
Kobayashi M, Tamari K, Salihi MO Al, et al. Anti-high mobility group box 1 antibody suppresses local inflammatory reaction and facilitates olfactory nerve recovery following injury [J]. J Neuroinflammation, 2018, 15(1): 124.
|
| 7 |
Dayon L, Turck N, Garcí-Berrocoso T, et al. Brain extracellular fluid protein changes in acute stroke patients [J]. J Proteome Res, 2011, 10(3): 1043-1051.
|
| 8 |
Shichita T, Hasegawa E, Kimura A, et al. Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain [J]. Nat Med, 2012, 18(6): 911-917.
|
| 9 |
Wake H, Moorhouse AJ, Jinno S, et al. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals [J]. J Neurosci, 2009, 29(13): 3974-3980.
|
| 10 |
Neher JJ, Emmrich JV, Fricker M, et al. Phagocytosis executes delayed neuronal death after focal brain ischemia [J]. Proc Natl Acad Sci U S A, 2013, 110(43): E4098-E4107.
|
| 11 |
Nowicka D, Rogozinska K, Aleksy M, et al. Spatiotemporal dynamics of astroglial and microglial responses after photothrombotic stroke in the rat brain [J]. Acta Neurobiol Exp(Wars), 2008, 68(2): 155-168.
|
| 12 |
Murphy JM, Jeong K, Rodriguez YAR, et al. FAK and Pyk2 activity promote TNF-α and IL-1β-mediated pro-inflammatory gene expression and vascular inflammation [J]. Scientific reports, 2019, 9(1): 7617.
|
| 13 |
Sotgiu S, Zanda B, Marchetti B, et al. Inflammatory biomarkers in blood of patients with acute brain ischemia [J]. EurJ Neurol, 2006, 13(5): 505-513.
|
| 14 |
Zaremba J, Losy J. The levels of TNF-alpha in cerebrospinal fluid and serum do not correlate with the counts of the white blood cells in acute phase of ischaemic stroke [J]. Folia morphol(Warsz), 2001, 60(2): 91-97.
|
| 15 |
Broughton BR, Reutens DC, Sobey CG. Apoptotic mechanisms after cerebral ischemia [J]. Stroke, 2009, 40(5): e331-e339.
|
| 16 |
Ekdahl CT, Kokaia Z, Lindvall O. Brain inflammation and adult neurogenesis: the dual role of microglia [J]. Neuroscience, 2009, 158(3): 1021-1029.
|
| 17 |
Ahmad M, Dar NJ, Bhat ZS, et al. Inflammation in ischemic stroke: mechanisms, consequences and possible drug targets [J]. CNS Neurol Disord Drug Targets, 2014, 13(8): 1378-1396.
|
| 18 |
Brough D, Tyrrell PJ, Allan SM. Regulation of interleukin-1 in acute brain injury [J]. Trends in pharmacological sciences, 2011, 32(10): 617-622.
|
| 19 |
Emsley HC, Smith CJ, Georgiou RF, et al. A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients [J]. J Neurol Neurosur Psychiatry, 2005, 76(10): 1366-1372.
|
| 20 |
Amantea D, Nappi G, Bernardi G, et al. Post-ischemic brain damage: pathophysiology and role of inflammatory mediators [J]. FEBS J, 2009, 276(1): 13-26.
|
| 21 |
Shukla V, Shakya AK, Perez-Pinzon MA, et al. Cerebral ischemic damage in diabetes: an inflammatory perspective [J]. J Neuroinflammation, 2017, 14(1): 21.
|
| 22 |
Wolinski P, Glabinski A. Chemokines and neurodegeneration in the early stage of experimental ischemic stroke [J]. Mediators Inflamm, 2013, 2013: 727189.
|
| 23 |
Rossi B, Angiari S, Zenaro E, et al. Vascular inflammation in central nervous system diseases: adhesion receptors controlling leukocyte-endothelial interactions [J]. J Leukoc Biol, 2011, 89(4): 539-556.
|
| 24 |
Yilmaz G, Granger DN. Cell adhesion molecules and ischemic stroke [J]. Neurol Res, 2008, 30(8): 783-793.
|
| 25 |
Greco R, Demartini C, Zanaboni AM, et al. Modulation of cerebral RAGE expression following nitric oxide synthase inhibition in rats subjected to focal cerebral ischemia [J]. Eur J Pharmacol, 2017, 800: 16-22.
|
| 26 |
Maestrini I, Strbian D, Gautier S, et al. Higher neutrophil counts before thrombolysis for cerebral ischemia predict worse outcomes [J]. Neurology, 2015, 85(16): 1408-1416.
|
| 27 |
Jorch SK, Kubes P. An emerging role for neutrophil extracellular traps in noninfectious disease [J]. Nat Med, 2017, 23(3): 279-287.
|
| 28 |
Mildner A, Schmidt H, Nitsche M, et al. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions [J]. Nat Neurosci, 2007, 10(12): 1544-1553.
|
| 29 |
Schroeter M, Jander S, Witte OW, et al. Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion [J]. J Neuroimmunol, 1994, 55(2): 195-203.
|
| 30 |
Zhang S, Zhou Y, Zhang R, et al. Rationale and design of combination of an immune modulator fingolimod with alteplase bridging with mechanical thrombectomy in acute ischemic stroke (FAMTAIS) trial [J]. Int J Stroke, 2017, 12(8): 906-909.
|
| 31 |
Planas AM, Gómez-Choco M, Urra X, et al. Brain-derived antigens in lymphoid tissue of patients with acute stroke [J]. J Immunol, 2012, 188(5): 2156-2163.
|
| 32 |
Dev KK, Mullershausen F, Mattes H, et al. Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis [J]. Pharmacol Ther, 2008, 117(1): 77-93.
|
| 33 |
Gelderblom M, Weymar A, Bernreuther C, et al. Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke [J]. Blood, 2012, 120(18): 3793-3802.
|
| 34 |
Baron JC, Moseley ME. For how long is brain tissue salvageable? Imaging-based evidence [J]. J Stroke Cerebrovasc Dis, 2000, 9(6 Pt 2): 15-20.
|
| 35 |
Sohrabji F, Williams M. Stroke neuroprotection: oestrogen and insulin-like growth factor-1 interactions and the role of microglia [J]. J Neuroendocrinol, 2013, 25(11): 1173-1181.
|
| 36 |
Patel AR, Ritzel R, McCullough LD, et al. Microglia and ischemic stroke: a double-edged sword [J]. IJPPP, 2013, 5(2): 73-90.
|
| 37 |
Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? [J]. Nat Neurosci, 2016, 19(8): 987-991.
|
| 38 |
Boutej H, Rahimian R, Thammisetty SS, et al. Diverging mRNA and protein networks in activated microglia reveal SRSF3 suppresses translation of highly upregulated innate immune transcripts [J]. Cell Rep, 2017, 21(11): 3220-3233.
|
| 39 |
Shichita T, Ito M, Morita R, et al. MAFB prevents excess inflammation after ischemic stroke by accelerating clearance of damage signals through MSR1 [J]. Nat Med, 2017, 23(6): 723-732.
|